ES523609A0 - Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. - Google Patents
Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.Info
- Publication number
- ES523609A0 ES523609A0 ES523609A ES523609A ES523609A0 ES 523609 A0 ES523609 A0 ES 523609A0 ES 523609 A ES523609 A ES 523609A ES 523609 A ES523609 A ES 523609A ES 523609 A0 ES523609 A0 ES 523609A0
- Authority
- ES
- Spain
- Prior art keywords
- imidazolylic
- derivatives
- preparing
- procedure
- bicycle compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8219412 | 1982-07-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES523609A0 true ES523609A0 (es) | 1985-03-01 |
| ES8503669A1 ES8503669A1 (es) | 1985-03-01 |
Family
ID=10531484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES523609A Expired ES8503669A1 (es) | 1982-07-05 | 1983-06-27 | Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US4510149A (es) |
| JP (1) | JPS5927874A (es) |
| KR (1) | KR910000414B1 (es) |
| AT (1) | AT386201B (es) |
| AU (1) | AU557304B2 (es) |
| BE (1) | BE897207A (es) |
| CA (1) | CA1202030A (es) |
| CH (1) | CH655102A5 (es) |
| CS (1) | CS273310B2 (es) |
| CZ (1) | CZ413491A3 (es) |
| DE (1) | DE3324069C2 (es) |
| DK (1) | DK163359C (es) |
| ES (1) | ES8503669A1 (es) |
| FI (1) | FI74466C (es) |
| FR (1) | FR2529547B1 (es) |
| GR (1) | GR77577B (es) |
| HK (1) | HK101187A (es) |
| HU (1) | HU193529B (es) |
| IE (1) | IE55894B1 (es) |
| IL (1) | IL69152A0 (es) |
| IT (1) | IT1163641B (es) |
| LU (1) | LU84895A1 (es) |
| MY (1) | MY104376A (es) |
| NL (1) | NL8302347A (es) |
| NO (1) | NO161439C (es) |
| NZ (1) | NZ204802A (es) |
| PH (1) | PH21115A (es) |
| PT (1) | PT76979B (es) |
| SE (1) | SE461791B (es) |
| SG (1) | SG73487G (es) |
| SU (1) | SU1342414A3 (es) |
| YU (1) | YU43545B (es) |
| ZA (1) | ZA834865B (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
| JPH062745B2 (ja) * | 1984-07-16 | 1994-01-12 | 第一製薬株式会社 | インダン誘導体 |
| US4659730A (en) * | 1984-06-18 | 1987-04-21 | Eli Lilly And Company | Aromatase inhibiting imidazole derivatives |
| GB2167408B (en) * | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
| GB8612796D0 (en) * | 1986-05-27 | 1986-07-02 | Fbc Ltd | Fungicides |
| JPS63310825A (ja) * | 1987-06-03 | 1988-12-19 | フアルミタリア・カルロ・エルバ・エツセ・エルレ・エルレ | 医薬に有用な二環式化合物のｎ−イミダゾリル誘導体 |
| US4992465A (en) * | 1988-09-27 | 1991-02-12 | Ciba-Geigy Corporation | 3-amino-dihydro-(1)-benzopyrans |
| IL91542A0 (en) * | 1988-10-06 | 1990-04-29 | Erba Carlo Spa | N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them |
| GB9025848D0 (en) * | 1990-11-28 | 1991-01-09 | Erba Carlo Spa | Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
| GB9102862D0 (en) * | 1991-02-11 | 1991-03-27 | Erba Carlo Spa | N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans |
| GB9127050D0 (en) * | 1991-12-20 | 1992-02-19 | Orion Yhtymae Oy | Substituted imidazole derivatives and their preparation and use |
| GB9127430D0 (en) * | 1991-12-27 | 1992-02-19 | Scras | Benzofuranylimidazole derivatives |
| US5837702A (en) * | 1993-10-07 | 1998-11-17 | Bristol-Myers Squibb Co. | 4-arylamino-benzopyran and related compounds |
| US5559248A (en) * | 1995-04-05 | 1996-09-24 | Bristol-Myers Squibb Co. | Retinoid-like heterocycles |
| US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
| US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
| US5612323A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phosphinic ester substituted benzopyran derivatives |
| GB9520150D0 (en) | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
| GC0000177A (en) | 1998-12-17 | 2006-03-29 | Smithkline Beecham | Thrombopoietin mimetics |
| CY2010012I2 (el) * | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
| US20110212054A1 (en) * | 2000-05-25 | 2011-09-01 | Glaxosmithkline Llc. | Thrombopoietin mimetics |
| DE10054639B4 (de) * | 2000-11-03 | 2004-05-06 | Jenapharm Gmbh & Co. Kg | Verwendung von RanBPM als Co-Modulator von Steroidhormonrezeptoren |
| JP2004527541A (ja) | 2001-03-01 | 2004-09-09 | スミスクライン・ビーチャム・コーポレイション | トロンボポエチン模倣物 |
| AR040083A1 (es) | 2002-05-22 | 2005-03-16 | Smithkline Beecham Corp | Compuesto bis-(monoetanolamina) del acido 3'-[(2z)-[1-(3,4-dimetilfenil) -1,5-dihidro-3-metil-5-oxo-4h-pirazol-4-iliden] hidrazino] -2'-hidroxi-[1,1'-bifenil]-3-carboxilico, procedimiento para prepararlo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion farmac |
| CN100586935C (zh) * | 2003-04-16 | 2010-02-03 | 亨斯迈先进材料（瑞士）有限公司 | 1-咪唑甲基-取代的2-萘酚及其作为低温固化促进剂的用途 |
| TW200526638A (en) * | 2003-10-22 | 2005-08-16 | Smithkline Beecham Corp | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| US9271963B2 (en) * | 2005-03-03 | 2016-03-01 | Universitat Des Saarlandes | Selective inhibitors of human corticosteroid synthases |
| CA2672286A1 (en) * | 2006-12-18 | 2008-06-26 | Novartis Ag | Organic compounds |
| ECSP077628A (es) * | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
| JP2012528184A (ja) | 2009-05-29 | 2012-11-12 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | トロンボポエチンアゴニスト化合物の投与の方法 |
| US10662171B2 (en) * | 2014-08-08 | 2020-05-26 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2443671A (en) * | 1942-12-03 | 1948-06-22 | Westinghouse Electric Corp | Arc welding system |
| US3485917A (en) * | 1966-04-14 | 1969-12-23 | Janssen Pharmaceutica Nv | Composition and method for combating fungus with imidazole carboxylates |
| US3541109A (en) * | 1968-06-25 | 1970-11-17 | Du Pont | 1-substituted imidazoles useful in acth reserve assay |
| US3637731A (en) * | 1968-07-18 | 1972-01-25 | Du Pont | 1-(alkylsubstituted phenyl)imidazoles useful in acth reserve assay |
| IE40911B1 (en) * | 1974-04-11 | 1979-09-12 | Schering Ag | Imidazole derivatives and process for their manufacture |
| DE2418502C3 (de) * | 1974-04-11 | 1980-04-24 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4284641A (en) * | 1977-08-26 | 1981-08-18 | Burroughs Wellcome Co. | Pharmaceutically active imidazole derivatives |
| JPS55313A (en) * | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
| JPS5681566A (en) * | 1979-12-05 | 1981-07-03 | Yoshitomi Pharmaceut Ind Ltd | Imidazole derivative |
| ATE43335T1 (de) * | 1980-02-14 | 1989-06-15 | Sandoz Ag | Peptide die einen (1s,2r,3r)- oder (1r,2s,3s)-1nitrilo-1-carbonyl-3-methyl-2-oxyheptan oder hept-5-en-rest enthalten brauchbar in totaler synsthese von cyclosporinen, und verfahren zu ihrer herstellung. |
| ZA81980B (en) * | 1980-03-04 | 1982-02-24 | Erba Farmitalia | N-imidazolyl derivatives of 1-chroman and process for their preparation |
| IL62122A0 (en) * | 1980-03-04 | 1981-03-31 | Erba Farmitalia | N-imidazolyl derivatives of 1-chroman,their preparation and pharmaceutical compositions containing them |
| GB2071655B (en) * | 1980-03-04 | 1983-06-22 | Erba Farmitalia | N-amidazolyl derivatives of1-chroman and process for their preparation |
| ZA825142B (en) * | 1981-07-23 | 1983-04-27 | Erba Farmitalia | N-imidazolyl derivatives of 1,2,3,j-tetrahydro-naphthalene, indan and 2-substituted-1-chroman, and process for their preparation |
| IL66242A0 (en) * | 1981-07-23 | 1982-11-30 | Erba Farmitalia | N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them |
| ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| JPS6081566A (ja) * | 1983-10-07 | 1985-05-09 | Nissan Motor Co Ltd | ロツクアツプトルクコンバ−タのスリツプ制御装置 |
-
1983
- 1983-06-27 ES ES523609A patent/ES8503669A1/es not_active Expired
- 1983-07-01 YU YU1442/83A patent/YU43545B/xx unknown
- 1983-07-01 GR GR71829A patent/GR77577B/el unknown
- 1983-07-01 US US06/510,358 patent/US4510149A/en not_active Expired - Fee Related
- 1983-07-01 PH PH29170A patent/PH21115A/en unknown
- 1983-07-01 NL NL8302347A patent/NL8302347A/nl not_active Application Discontinuation
- 1983-07-01 IT IT21886/83A patent/IT1163641B/it active
- 1983-07-01 FI FI832420A patent/FI74466C/fi not_active IP Right Cessation
- 1983-07-04 DE DE3324069A patent/DE3324069C2/de not_active Expired - Fee Related
- 1983-07-04 PT PT76979A patent/PT76979B/pt unknown
- 1983-07-04 SU SU833622805A patent/SU1342414A3/ru active
- 1983-07-04 IE IE1564/83A patent/IE55894B1/en not_active IP Right Cessation
- 1983-07-04 IL IL69152A patent/IL69152A0/xx not_active IP Right Cessation
- 1983-07-04 JP JP58120440A patent/JPS5927874A/ja active Granted
- 1983-07-04 SE SE8303824A patent/SE461791B/sv not_active IP Right Cessation
- 1983-07-04 DK DK307983A patent/DK163359C/da not_active IP Right Cessation
- 1983-07-04 CA CA000431748A patent/CA1202030A/en not_active Expired
- 1983-07-04 ZA ZA834865A patent/ZA834865B/xx unknown
- 1983-07-04 HU HU832413A patent/HU193529B/hu not_active IP Right Cessation
- 1983-07-04 NZ NZ204802A patent/NZ204802A/en unknown
- 1983-07-04 LU LU84895A patent/LU84895A1/fr unknown
- 1983-07-04 BE BE0/211113A patent/BE897207A/fr not_active IP Right Cessation
- 1983-07-04 NO NO832437A patent/NO161439C/no unknown
- 1983-07-04 AU AU16540/83A patent/AU557304B2/en not_active Ceased
- 1983-07-04 FR FR8311098A patent/FR2529547B1/fr not_active Expired
- 1983-07-04 CH CH3666/83A patent/CH655102A5/de not_active IP Right Cessation
- 1983-07-05 AT AT0247383A patent/AT386201B/de not_active IP Right Cessation
- 1983-07-05 CS CS509483A patent/CS273310B2/cs unknown
- 1983-07-05 KR KR1019830003067A patent/KR910000414B1/ko not_active IP Right Cessation
-
1984
- 1984-11-21 US US06/673,722 patent/US4602022A/en not_active Expired - Fee Related
-
1987
- 1987-09-03 SG SG734/87A patent/SG73487G/en unknown
- 1987-12-31 HK HK1011/87A patent/HK101187A/xx unknown
-
1988
- 1988-12-30 MY MYPI88001593A patent/MY104376A/en unknown
-
1991
- 1991-12-30 CZ CS914134A patent/CZ413491A3/cs unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES523609A0 (es) | Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. | |
| MX7199E (es) | Procedimiento para preparar derivados de 3-cetodelta-4,9,19-nor-esteroides | |
| ES517332A0 (es) | Procedimiento para preparar derivados de feniltiadiazinona. | |
| AR240941A1 (es) | Procedimiento para preparar compuestos de pirazolopirimidinas | |
| MX161088A (es) | Procedimiento para preparar derivados de 1-metil-5-p-tolilpirrol-2-acetamida | |
| ES526738A0 (es) | Procedimiento para la preparacion de derivados de benzodioxino pirrol. | |
| ES539312A0 (es) | Procedimiento para preparar derivados de n-fenilpirazol | |
| ES522786A0 (es) | Procedimiento para preparar derivados de piperacina. | |
| MX157788A (es) | Procedimiento para preparar derivados de oxima | |
| ES524830A0 (es) | Procedimiento para preparar derivados de xantina | |
| AR231447A1 (es) | Procedimiento para preparar derivados de 4,5-dihidro-imidazo 1,2-a-quinazolin-2 1h-ona | |
| ES527945A0 (es) | Procedimiento para preparar derivados de bencilcarbamoilpiridina. | |
| ES527164A0 (es) | Procedimiento para preparar derivados de 2-piperacinil-quinazolina | |
| ES521847A0 (es) | Procedimiento para preparar derivados de pleuromutilina | |
| ES520537A0 (es) | Procedimiento para la preparacion de derivados de carbaciclina. | |
| ES532486A0 (es) | Procedimiento para producir derivados de tiatriazina | |
| ES525333A0 (es) | Procedimiento para preparar derivados de sulfamoilbenzofenona. | |
| ES509744A0 (es) | Procedimiento para preparar derivados sustituidos de tetrahidropirimidinona. | |
| AR230629A1 (es) | Procedimiento para preparar compuestos de dihalogenotriacinil-aminonaftol | |
| ES515767A0 (es) | Procedimiento para preparar derivados de indano. | |
| ES515568A0 (es) | Procedimiento para preparar derivados de fenantreno. | |
| ES506012A0 (es) | Procedimiento para preparar compuestos de halogenotriazinilo | |
| ES519085A0 (es) | Procedimiento para la preparacion de compuestos de benzotiazol. | |
| ES522653A0 (es) | Procedimiento de preparacion de derivados de piperacina. | |
| ES504681A0 (es) | Procedimiento para preparar derivados de 11- hidroxi-13 oxa-prostaglandina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970519 |